Skip to content
HowShorted

Tabula Rasa HealthCare, Inc. short interest in 2021

In 2021, Tabula Rasa HealthCare, Inc.'s disclosed short interest ran from 25.59% of shares outstanding on 15 Jan 2021 to 9.63% on 31 Dec 2021, a change of -15.96 percentage points. The year's high was 25.59% on 15 Jan 2021 and its low 6.98% on 30 Nov 2021, averaging 12.09% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.41 days on 28 May 2021. Full history: Tabula Rasa HealthCare, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Tabula Rasa HealthCare, Inc. in 2021

2021 in figures

Start of year
25.59% (15 Jan 2021)
End of year
9.63% (31 Dec 2021)
Change
-15.96 pp
High
25.59% (15 Jan 2021)
Low
6.98% (30 Nov 2021)
Average
12.09%
Highest days to cover
19.41 (28 May 2021)
SEC filings marked
9

Every report in 2021

Tabula Rasa HealthCare, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202125.59%13.93results (8-K)
29 Jan 202123.60%11.98
12 Feb 202120.65%12.94
26 Feb 202120.85%11.56results (8-K), 10-K filed
15 Mar 202115.02%5.97
31 Mar 202113.06%10.55
15 Apr 202112.34%17.89
30 Apr 202111.63%19.02
14 May 202111.45%14.66results (8-K), 10-Q filed
28 May 202111.40%19.41
15 Jun 202110.55%12.23
30 Jun 20219.21%10.19
15 Jul 20219.25%13.33
30 Jul 20219.41%10.37
13 Aug 20219.47%8.63results (8-K), 10-Q filed
31 Aug 20219.69%7.63
15 Sep 20219.14%8.68
30 Sep 20218.64%6.29
15 Oct 20218.19%7.25
29 Oct 20217.91%10.73
15 Nov 20217.41%1.82results (8-K), 10-Q filed
30 Nov 20216.98%3.32
15 Dec 20219.04%2.18
31 Dec 20219.63%3.15

See also: Tabula Rasa HealthCare, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.